MedPath

Effect of Intraperitoneal Infiltration of Bupivacaine and Fentanyl Combination on the Pain Control after Diagnostic Gynecologic Laparoscopy

Not Applicable
Conditions
pain due to diagnostic laparoscopy.
Female infertility
Registration Number
IRCT201212267013N4
Lead Sponsor
Vice Chancellor for Research, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Patients scheduled for diagnostic gynecologic laparoscopy; patients aged 18–40 yr; patients with ASA class I or II.
Exclusion criteria: Patients with a history of allergy to local anesthetics; patients with a history of systemic disease or psychological disorders; patients with a history of chronic pain syndrome; Patients with a history of NSAIDS or any other analgesic consumption.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: PACU, every 1 hour until 4 hours and then every 4 hours until 24 hours after operation. Method of measurement: Visual analogue scale (VAS) from 0 (without pain) to 10 (severe and intolerable pain).
Secondary Outcome Measures
NameTimeMethod
Dose of analgesic requirements. Timepoint: PACU, every 1 h until 4 h and then every 4 h until 24 h after operation. Method of measurement: Injection number and injection dose in mg.
© Copyright 2025. All Rights Reserved by MedPath